Coloplast AS Profit Margin

Coloplast AS posts a profit margin of 8.86% as of June 2026. That compares with 14.62% in the prior-year period — down 39.4% year over year. That is below the Healthcare sector average of 13.89%. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Coloplast AS's profit margin was 14.62%. The latest reading is 8.86% — a 39.4% year-over-year decrease (period ending June 2026). Use the history and growth charts on this page for a longer lookback.

For Healthcare stocks, a profit margin near 13.89% is typical. Coloplast AS's 8.86% is lower that level. That is roughly 36.2% below the sector mean. Whether that is a warning or an opportunity depends on growth outlook and other fundamentals shown elsewhere on Stockcircle.

Coloplast AS's profit margin moves when the underlying profit, equity, or asset base changes. Cost cuts, pricing power, buybacks, write-downs, and cyclical swings can all shift the percentage. The latest reading is 8.86% as of June 2026; use YoY and peer views to separate noise from signal.

Context for CLPBY's profit margin usually means three checks: (1) trend versus prior periods, (2) level versus peers (average 13.89%), and (3) consistency with growth and profitability. This page covers the first two; Coloplast AS's other metric pages and overview cover the third.